Interlaminar Device Market Share

North American Market Statistics

North America industry is anticipated to account for largest revenue share of 38% by 2037. The market growth in the region is impelled by the rising adoption of interlaminar devices in the region. Countries such as the US, Mexico, and Canada are reported to have rising cases of spinal cord injuries resulting from road traffic accidents, falls, or rising aging populations. For instance, in the U.S., 21.5% of adults were found to include sports and exercise in their daily routines in 2021. Further, this is most likely to rise the demand for the interlaminar device in the area as it is used to stabilize the spine and protect it from any severe damage.

European Market Forecast

The European interlaminar device market is estimated to be the second largest with a share of 26%, during the forecast timeframe. The European market is poised to observe a dominant market for interlaminar devices as a result of better healthcare infrastructure, greater awareness, an improved reimbursement picture, and expanding insurance coverage.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of interlaminar device is estimated at USD 693.15 million.

The interlaminar device market size was valued at USD 629.19 million in 2024 and is likely to cross USD 1.37 billion by 2037, expanding at more than 6.2% CAGR during the forecast period i.e., between 2025-2037. Growing Cases of Sports Injuries and the growing advancements in spine surgery technologies across the globe will boost the market growth.

North America industry is anticipated to account for largest revenue share of 38% by 2037, impelled by rising adoption of interlaminar devices in the region.

The major players in the market are NuVasive, Inc., Zimmer Biomet, Life Spine, Inc., Xtant Medical, Alphatec Holdings, Inc., Amedica Corporation, Paradigm Health System, Bioventus LLC, Medical Device Business Services, Inc., Meditech Spine, LLC

Interlaminar Device Market Share